The most common adverse effects in studies were upper respiratory tract infection, headache, nausea, and diarrhea.
Abrocitinib
Baricitinib
Gilteritinib
Erdafitinib
Upadacitinib
Tucatinib
Delgocitinib
Oclacitinib